MEI Pharma, Inc. (MEIP) in Focus: Stock up 12.1% - Tale of the Tape

MEI Pharma, Inc. MEIP was a big mover last session, as the company saw its shares rise over 12% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $8.45 to $11.45 in the past one-month time frame, showed a pick-up yesterday at $11.21.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday's price action is encouraging, so make sure to keep a close watch on this firm in the near future.

MEI Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some other stocks worth considering in the healthcare industry include Alexion Pharmaceuticals, Inc. ALXN and Aastrom Biosciences, Inc. ASTM with a Zacks Rank #1 (Strong Buy) along with Cambrex Corporation.CBM holding a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALEXION PHARMA ALXN: Free Stock Analysis Report

AASTROM BIOSCI ASTM: Get Free Report

CAMBREX CORP CBM: Free Stock Analysis Report

MEI PHARMA INC MEIP: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs